Japan-based Takeda Pharmaceutical invests $25m in drug discovery firm BioMotiv
Introduction
BioMotiv and Takeda Pharmaceutical Company has entered into Strategic Partnership,where Takeda has made a initial investment of $25million in BioMotiv.
Features
This partnership will leverage the strengths of both organizations to identify and develop pioneering medical innovations.
The $25 million investment includes exclusive rights relating to programs sourced by BioMotiv specifically in the therapeutic areas of Immunology & Inflammation and Cardio-metabolic Diseases.
Specifications Table:
- Company Name
- Takeda Pharmaceutical
- Company Invested In
- BioMotiv
- Location
- Cleveland, Ohio
- Date of Completion
- 2019
- Estimated Cost
- $25 million
